TP53 and cancer: Cancer cells compensate for glycolysis's low ATP yield via accelerated flux and glutamine metabolism, with feedback on PFK-1 overridden by elevated fructose-2,6-bisphosphate through PFKFB3/4, while downregulation of TIGAR in p53-mutant tumors sustains glycolysis [110,122].